ES2106838T3 - Dispositivo de liberacion en dispersion de un farmaco de liberacion controlado. - Google Patents

Dispositivo de liberacion en dispersion de un farmaco de liberacion controlado.

Info

Publication number
ES2106838T3
ES2106838T3 ES92311716T ES92311716T ES2106838T3 ES 2106838 T3 ES2106838 T3 ES 2106838T3 ES 92311716 T ES92311716 T ES 92311716T ES 92311716 T ES92311716 T ES 92311716T ES 2106838 T3 ES2106838 T3 ES 2106838T3
Authority
ES
Spain
Prior art keywords
dispersion
hydration
release
pharmacy
gelatinous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92311716T
Other languages
English (en)
Inventor
Gerald S Rork
James D Pipkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2106838T3 publication Critical patent/ES2106838T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PRESENTA UN DISPOSITIVO PARA EL SUMINISTRO CONTROLADO DE UN AGENTE BENEFICIOSO TAL COMO UNA DISPERSION GELATINOSA QUE CONSTA DE I) UN NUCLEO QUE CONTIENE UN AGENTE BENEFICIOSO, UN POLIMERO QUE FORMA PARTICULAS MICROSCOPICAS GELATINOSAS DESPUES DE SU HIDRATACION Y SI SE DESEA UN AGENTE PARA MODULAR LA HIDRATACION DEL POLIMERO; Y II) UN RECUBRIMIENTO INSOLUBLE E IMPERMEABLE QUE SE ADHIERE Y RODEA EL NUCLEO Y CONTIENE APERTURAS QUE SUMINISTRAN UN AREA PARA LA HIDRATACION Y LIBERACION DE UNA DISPERSION QUE COMPRENDA PARTICULAS MICROSCOPICAS GELATINOSAS.
ES92311716T 1991-12-27 1992-12-22 Dispositivo de liberacion en dispersion de un farmaco de liberacion controlado. Expired - Lifetime ES2106838T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81530491A 1991-12-27 1991-12-27
US90218892A 1992-07-29 1992-07-29

Publications (1)

Publication Number Publication Date
ES2106838T3 true ES2106838T3 (es) 1997-11-16

Family

ID=27123932

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92311716T Expired - Lifetime ES2106838T3 (es) 1991-12-27 1992-12-22 Dispositivo de liberacion en dispersion de un farmaco de liberacion controlado.

Country Status (26)

Country Link
EP (1) EP0549331B1 (es)
JP (1) JPH089534B2 (es)
KR (1) KR100281609B1 (es)
CN (1) CN1074368A (es)
AT (1) ATE157001T1 (es)
AU (1) AU660057B2 (es)
BG (1) BG61751B1 (es)
CA (1) CA2085871C (es)
CZ (1) CZ284045B6 (es)
DE (1) DE69221711T2 (es)
DK (1) DK0549331T3 (es)
ES (1) ES2106838T3 (es)
FI (1) FI109451B (es)
GR (1) GR3024885T3 (es)
HU (1) HU219594B (es)
IL (1) IL104189A (es)
LV (1) LV12082B (es)
MX (1) MX9207541A (es)
NO (1) NO310672B1 (es)
NZ (1) NZ245514A (es)
PL (1) PL171110B1 (es)
RO (1) RO112810B1 (es)
RU (1) RU2127586C1 (es)
SK (1) SK279964B6 (es)
WO (1) WO1993012765A1 (es)
YU (1) YU48762B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
ES2175676T3 (es) * 1997-01-14 2002-11-16 Lohmann Therapie Syst Lts Sistema terapeutico expansible de retencion gastrica con liberacion controlada de principio activo en el tracto gastrointestinal.
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6506397B1 (en) * 1999-02-19 2003-01-14 Curt Thies Pest controlling
AU3957400A (en) 1999-04-16 2000-11-02 Novo Nordisk A/S Dry, mouldable drug formulation
JP2003501375A (ja) * 1999-06-04 2003-01-14 アルザ・コーポレーション 移植可能なゲル組成物および製造方法
AU2001276748A1 (en) * 2000-08-08 2002-02-18 Daiichi Pharmaceutical Co., Ltd. Highly absorbable solid preparation
RU2165251C1 (ru) * 2000-09-06 2001-04-20 Федеральное государственное унитарное предприятие Московское производственное химико-фармацевтическое объединение им. Н.А. Семашко Твердая лекарственная форма эналаприла и способ ее получения
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
RU2179022C1 (ru) * 2001-04-19 2002-02-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая противоязвенная композиция и способ ее получения
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
AU2002353659A1 (en) * 2001-12-18 2003-07-15 Synthon B.V. Simvastatin dosage forms
WO2003051328A1 (en) * 2001-12-18 2003-06-26 Novo Nordisk A/S Solid dose micro implant
TWI353854B (en) * 2002-06-25 2011-12-11 Alza Corp Short duration depot formulations
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
EP1542662A1 (en) * 2002-09-28 2005-06-22 McNEIL-PPC, INC. Immediate release dosage form comprising shell having openings therein
RU2225200C1 (ru) * 2002-12-23 2004-03-10 Общество с ограниченной ответственностью Научно-производственное предприятие "Поликом" Фармацевтический состав с противогерпесной активностью и способ лечения вирусной инфекции
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
RU2248199C1 (ru) * 2003-06-02 2005-03-20 Открытое Акционерное Общество "Акционерное Курганское общество медицинских препаратов и изделий "Синтез" (ОАО "Синтез") Глазные капли и способ их получения
AU2005269988B2 (en) 2004-07-02 2012-02-02 Mati Therapeutics Inc. Treatment medium delivery device and methods for delivery
KR20090006153A (ko) 2006-03-31 2009-01-14 큐엘티 플러그 딜리버리, 인코포레이티드 비루관계에 대한 약물 전달 방법, 구조, 및 조성물
US9011361B2 (en) 2007-09-07 2015-04-21 Mati Therapeutics Inc. Lacrimal implant detection
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
US20130053794A1 (en) 2011-08-29 2013-02-28 Suzanne Cadden Sustained release delivery of active agents to treat glaucoma and ocular hypertension
JP7626361B2 (ja) * 2018-10-25 2025-02-07 株式会社ダイセル １型ヘルパーｔ細胞増加剤、食品、及び医薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5057321A (en) * 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin

Also Published As

Publication number Publication date
NZ245514A (en) 1994-12-22
LV12082A (lv) 1998-07-20
IL104189A0 (en) 1993-05-13
AU3034892A (en) 1993-08-12
RU94031474A (ru) 1997-04-20
SK279964B6 (sk) 1999-06-11
HUT70437A (en) 1995-10-30
DE69221711D1 (de) 1997-09-25
CZ284045B6 (cs) 1998-07-15
DE69221711T2 (de) 1998-03-12
EP0549331A1 (en) 1993-06-30
CZ157094A3 (en) 1994-12-15
IL104189A (en) 1996-10-31
RO112810B1 (ro) 1998-01-30
AU660057B2 (en) 1995-06-08
FI109451B (fi) 2002-08-15
CN1074368A (zh) 1993-07-21
KR100281609B1 (ko) 2001-02-15
BG61751B1 (bg) 1998-05-29
KR940703653A (ko) 1994-12-12
NO942430L (no) 1994-06-27
SK76994A3 (en) 1995-05-10
JPH05255071A (ja) 1993-10-05
BG98805A (bg) 1995-03-31
NO942430D0 (no) 1994-06-27
CA2085871A1 (en) 1993-06-28
FI943011L (fi) 1994-06-22
ATE157001T1 (de) 1997-09-15
MX9207541A (es) 1994-06-30
NO310672B1 (no) 2001-08-13
YU48762B (sh) 1999-11-22
GR3024885T3 (en) 1998-01-30
JPH089534B2 (ja) 1996-01-31
LV12082B (en) 1998-09-20
PL171110B1 (pl) 1997-03-28
DK0549331T3 (da) 1997-09-15
HU9401913D0 (en) 1994-09-28
FI943011A0 (fi) 1994-06-22
WO1993012765A1 (en) 1993-07-08
CA2085871C (en) 2002-05-07
HU219594B (hu) 2001-05-28
RU2127586C1 (ru) 1999-03-20
YU111292A (sh) 1995-12-04
EP0549331B1 (en) 1997-08-20

Similar Documents

Publication Publication Date Title
MX9207541A (es) Aparato para suministro de dispersion de droga conliberacion controlada.
ES2141713T3 (es) Formulaciones estabilizadas de liberacion controlada recubiertas de una capa de polimero acrilico.
DE69407404D1 (de) Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung
ES2101082T3 (es) Composiciones de liberacion controlada.
ES2054813T3 (es) Formulacion de acetaminofen de liberacion sostenida por via oral y procedimiento para obtenerla.
MX9704672A (es) Dispositivo surtidor de suspension de farmaco, de liberacion controlada.
PA7695401A1 (es) Comprimidos dispersos en agua
DE69807104D1 (de) Formulierungen mit gesteuerter freisetzung
AR003626A1 (es) Composicion tixotropica de limpieza de superficies duras y uso de dicha composicion
ES2132758T5 (es) Nucleo de articulos absorbentes estirables.
ES2152986T3 (es) Genoterapia de celulas mesoteliales.
ES2071494T3 (es) Procedimiento para la preparacion de composiciones para lavavajillas no fosfatadas con sistemas blanqueadores de oxigeno.
ES2194863T3 (es) Materiales farmaceuticos con enmascarado de sabor.
ES2125259T3 (es) Dispositivos de distribucion de farmacos de liberacion sostenida.
ES2138584T3 (es) Sistema de suministro de farmacos que implica la reaccion entre una proteina o un polipeptido y un polimero biodegradable hidrofobo.
ES2153229T3 (es) Granulado densificado, procedimiento para su fabricacion y su utilizacion como agente desintegrador para cuerpos moldeados por compactacion.
ES2066956T3 (es) Material en forma de hoja intumescente.
AR241676A1 (es) Suministrador de agente beneficioso a un ambiente de uso.
ES2137189T3 (es) Peliculas biodegradables e impermeables a liquidos.
ES2056423T3 (es) Microesferas compuestas magnetizables a base de un polimero organosiliciado reticulado, su procedimiento de preparacion y su aplicacion en biologia.
AR017131A1 (es) Una composicion para el lavado en maquina lavavajilla
ES2080497T3 (es) Bloques para la limpieza de inodoros.
AR026968A1 (es) Una tableta matriz que permite la liberacion prolongada de trimetazidina lluego de su administracion por via oral
ES2059299T3 (es) Direccionado de agentes terapeuticos utilizando polisacaridos.
PA7116401A1 (es) Metodos y aparatos para crear un revestimiento de gelatina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 549331

Country of ref document: ES